1. Home
  2. CLAR vs ZNTL Comparison

CLAR vs ZNTL Comparison

Compare CLAR & ZNTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Clarus Corporation

CLAR

Clarus Corporation

N/A

Current Price

$3.39

Market Cap

129.8M

ML Signal

N/A

Logo Zentalis Pharmaceuticals Inc.

ZNTL

Zentalis Pharmaceuticals Inc.

N/A

Current Price

$1.34

Market Cap

118.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CLAR
ZNTL
Founded
1957
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Recreational Games/Products/Toys
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
129.8M
118.3M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
CLAR
ZNTL
Price
$3.39
$1.34
Analyst Decision
Strong Buy
Buy
Analyst Count
3
6
Target Price
$5.33
$5.87
AVG Volume (30 Days)
132.2K
508.5K
Earning Date
11-06-2025
11-10-2025
Dividend Yield
2.98%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$256,432,000.00
$26,865,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$3.85
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.02
$1.01
52 Week High
$5.08
$3.33

Technical Indicators

Market Signals
Indicator
CLAR
ZNTL
Relative Strength Index (RSI) 45.27 42.04
Support Level $3.33 $1.34
Resistance Level $3.71 $1.45
Average True Range (ATR) 0.13 0.07
MACD -0.02 0.00
Stochastic Oscillator 11.84 14.71

Price Performance

Historical Comparison
CLAR
ZNTL

About CLAR Clarus Corporation

Clarus Corp is a designer, developer, manufacturer, and distributor of outdoor equipment and lifestyle products focused on the climb, ski, mountain, sport, and skincare markets. The company operates through the Outdoor segment, which includes Black Diamond Equipment and PIEPS, is a world-wide leader in designing, manufacturing, and marketing outdoor engineered equipment and apparel for climbing, mountaineering, trail running, backpacking, skiing, and a wide range of other year-round outdoor recreation activities. The Adventure segment, which includes Rhino-Rack, MAXTRAX and TRED, is a manufacturer of engineered automotive roof racks, trays, mounting systems, luggage boxes, carriers, recovery boards and accessories in Australia and New Zealand and United States.

About ZNTL Zentalis Pharmaceuticals Inc.

Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin E1-positive platinum-resistant ovarian cancer (Cyclin E1+ PROC). The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions.

Share on Social Networks: